Literature DB >> 15920556

Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index.

John S Meyer1, Consuelo Alvarez, Clara Milikowski, Neal Olson, Irma Russo, Jose Russo, Andrew Glass, Barbara A Zehnbauer, Karen Lister, Reza Parwaresch.   

Abstract

Questions of reproducibility and efficacy of histologic malignancy grading relative to alternative proliferation index measurements for outcome prediction remain unanswered. Microsections of specimens from the Cooperative Breast Cancer Tissue Resource (CBCTR) were evaluated by seven pathologists for reproducibility of grade and classification. Nuclear figure classification was assessed using photographs. Grade was assigned by the Bloom-Richardson method, Nottingham modification. Proliferation index was evaluated prospectively by deoxyribose nucleic acid precursor uptake with thymidine (autoradiographic) or bromodeoxyuridine (immunohistochemical) labeling index using fresh tissue from 631 node-negative breast cancer patients accessioned at St Luke's Hospital. A modified Nottingham-Bloom-Richardson grade was derived from histopathologic data. Median post-treatment observation was 6.4 years. Agreement on classification of nuclear figures (N=43) was less than good by kappa statistic (kappa=0.38). Grade was moderately reproducible in four trials (N=10,10,19, 10) with CBCTR specimens (kappa=0.50-0.59). Of components of Bloom-Richardson grade, agreement was least for nuclear pleomorphism (kappa=0.37-0.50), best for tubularity (kappa=0.57-0.83), and intermediate for mitotic count (kappa=0.45-0.64). Bloom-Richardson grade was a univariate predictor of prognosis in node-negative St Luke's patients, and was improved when mitotic count was replaced by labeling index (low, mid, or high). When labeling index was added to a multivariate model containing tumor size and vessel invasion, grade was no longer a significant predictor of tumor-specific relapse-free or overall survival. Mitotic index predicted best when intervals were lowered to 0-2, 3-10, and >10 mitotic figures per ten 0.18 mm(2) high-power fields. We conclude that Nottingham-Bloom-Richardson grades remain only modestly reproducible. Prognostically useful components of grade are mitotic index and tubularity. The Nottingham-Bloom-Richardson system can be improved by lowering cutoffs for mitotic index and by counting 20-30 rather than 10 high-power fields. Measurement of proliferation index by immunohistochemically detectable markers will probably give superior prognostic results in comparison to grade.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920556     DOI: 10.1038/modpathol.3800388

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  63 in total

1.  Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers.

Authors:  Cheng Lu; David Romo-Bucheli; Xiangxue Wang; Andrew Janowczyk; Shridar Ganesan; Hannah Gilmore; David Rimm; Anant Madabhushi
Journal:  Lab Invest       Date:  2018-06-29       Impact factor: 5.662

2.  A deep learning based strategy for identifying and associating mitotic activity with gene expression derived risk categories in estrogen receptor positive breast cancers.

Authors:  David Romo-Bucheli; Andrew Janowczyk; Hannah Gilmore; Eduardo Romero; Anant Madabhushi
Journal:  Cytometry A       Date:  2017-02-13       Impact factor: 4.355

3.  Exposure to the Endocrine Disruptor Bisphenol A Alters Susceptibility for Mammary Cancer.

Authors:  Coral A Lamartiniere; Sarah Jenkins; Angela M Betancourt; Jun Wang; Jose Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2011-03-01

4.  Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.

Authors:  Eman A Toraih; Eman A Mohammed; Sherif Farrag; Nevene Ramsis; Somaya Hosny
Journal:  Mol Diagn Ther       Date:  2015-06       Impact factor: 4.074

5.  [Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker].

Authors:  R von Wasielewski; K Klöpper; H J Lück; H Kreipe
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

6.  Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors.

Authors:  Annika Blank; Laura Wehweck; Ilaria Marinoni; Laura Amanda Boos; Frank Bergmann; Anja Maria Schmitt; Aurel Perren
Journal:  Virchows Arch       Date:  2015-09-17       Impact factor: 4.064

7.  Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats.

Authors:  Sarah Jenkins; Nandini Raghuraman; Isam Eltoum; Mark Carpenter; Jose Russo; Coral A Lamartiniere
Journal:  Environ Health Perspect       Date:  2009-01-07       Impact factor: 9.031

Review 8.  Reporting methods in studies developing prognostic models in cancer: a review.

Authors:  Susan Mallett; Patrick Royston; Susan Dutton; Rachel Waters; Douglas G Altman
Journal:  BMC Med       Date:  2010-03-30       Impact factor: 8.775

Review 9.  Reporting performance of prognostic models in cancer: a review.

Authors:  Susan Mallett; Patrick Royston; Rachel Waters; Susan Dutton; Douglas G Altman
Journal:  BMC Med       Date:  2010-03-30       Impact factor: 8.775

10.  In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat.

Authors:  Angela M Betancourt; Isam A Eltoum; Renee A Desmond; Jose Russo; Coral A Lamartiniere
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.